RWA Wealth Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.7M Buy
242,060
+153,460
+173% +$10.6M 0.21% 74
2025
Q1
$6.15M Sell
88,600
-2,223
-2% -$154K 0.08% 135
2024
Q4
$7.81M Buy
90,823
+29,787
+49% +$2.56M 0.1% 115
2024
Q3
$7.27M Sell
61,036
-22,537
-27% -$2.68M 0.09% 122
2024
Q2
$11.9M Sell
83,573
-4,340
-5% -$619K 0.16% 84
2024
Q1
$11.3M Sell
87,913
-4,893
-5% -$628K 0.15% 90
2023
Q4
$9.6M Buy
92,806
+72,924
+367% +$7.54M 0.14% 93
2023
Q3
$1.81M Buy
+19,882
New +$1.81M 0.04% 143
2023
Q2
Sell
-19,468
Closed -$1.55M 347
2023
Q1
$1.55M Hold
19,468
0.04% 110
2022
Q4
$1.29M Hold
19,468
0.03% 122
2022
Q3
$970K Hold
19,468
0.07% 123
2022
Q2
$1.09M Sell
19,468
-252
-1% -$14K 0.07% 121
2022
Q1
$1.1M Hold
19,720
0.07% 128
2021
Q4
$1.1M Sell
19,720
-1,244
-6% -$69.6K 0.07% 130
2021
Q3
$1.01M Sell
20,964
-1,028
-5% -$49.3K 0.08% 128
2021
Q2
$921K Sell
21,992
-172
-0.8% -$7.2K 0.07% 137
2021
Q1
$747K Buy
22,164
+424
+2% +$14.3K 0.06% 142
2020
Q4
$759K Buy
21,740
+1,244
+6% +$43.4K 0.07% 139
2020
Q3
$711K Buy
20,496
+28
+0.1% +$971 0.07% 127
2020
Q2
$670K Hold
20,468
0.08% 121
2020
Q1
$616K Sell
20,468
-1,000
-5% -$30.1K 0.09% 125
2019
Q4
$621K Buy
21,468
+1,000
+5% +$28.9K 0.06% 151
2019
Q3
$529K Sell
20,468
-1,000
-5% -$25.8K 0.06% 161
2019
Q2
$548K Hold
21,468
0.06% 155
2019
Q1
$561K Hold
21,468
0.06% 150
2018
Q4
$494K Sell
21,468
-550
-2% -$12.7K 0.07% 149
2018
Q3
$519K Hold
22,018
0.06% 143
2018
Q2
$508K Hold
22,018
0.06% 155
2018
Q1
$542K Sell
22,018
-600
-3% -$14.8K 0.07% 136
2017
Q4
$607K Buy
22,618
+1,000
+5% +$26.8K 0.07% 153
2017
Q3
$520K Buy
+21,618
New +$520K 0.06% 158